ABSTRACTS

Welcome

The organising and scientific committees cordially invite all Primary Care professionals working in the field of diabetes care to submit abstracts for oral / poster presentations. Authors are kindly requested to submit abstracts on this website only.

Listed below are the instructions for abstract submission. Abstract submitted by fax or e-mail will not be accepted.

Abstract Submission Deadline

  • FAST TRACK REVIEW* deadline:     JANUARY 31st, 2023 
  • REGULAR submission deadline:     Extended until APRIL 13th, 2023   (Abstract submission system will be automatically closed after this date)

(*) FAST TRACK REVIEW: 
Abstracts submitted before JANUARY 31st, 2023 will be eligible to fast track review and authors will receive notification of acceptance within 2 weeks after submission. Presenting authors of accepted abstracts will be eligible for Super Early Bird registration rates.


2020 CONFERENCE ABSTRACTS 
Abstracts submitted to 2020 PCDE Conference (which unfortunately had to be postponed due to the pandemic) have been revised by the scientific committee. Authors whose abstracts have been accepted have 3 options:

  1. Uphold your abstract. Your abstract remains as it is, it keeps the “accepted” status and you don’t have to resubmit it in our abstract submission system for 2023.
  2. In case you want to withdraw your abstract due to the conference postponement, please send an email to mricart@semfyc.es asking to withdraw your abstract from the PCDE conference (please provide abstract title or ID number). 
  3. In case you want to update your abstract you should resubmit it in the abstract submission system as if it was a new abstract, and send and email to mricart@semfyc.es asking to withdraw the previous one (please provide abstract title or ID number). The updated abstract will go through peer review again and it will be likely that it will be accepted again.

 

2023 CONFERENCE GENERAL POLICY AND PROCEDURE

    • All abstracts need to be submitted and presented in English.

    • Please pay attention to correct spelling, as there will be no subsequent proof-reading/corrections. The abstracts will be published exactly as submitted.

    • Do not enter references.

    • Avoid the use of symbols.

    • Maximum length: 2000 characters (incl. spaces) or 300 words. Title: maximum 200 character (incl. spaces).

    • The abstract is meant to obviously contribute to advance knowledge in the field of Diabetes in Primary Health Care, briefly stating: Standard abbreviations are accepted in the text. Unusual ones must be mentioned in brackets when used for the first time.

      • Aim(s) or purpose: indicate purpose of the study or hypothesis tested.
      • Design & method: include study setting, subjects (number and type), diagnosis or intervention and statistical analysis.
      • Results: present as clearly as possible study outcomes and statistical significance besides clinical relevance.
      • Conclusions: briefly discuss data and emphasize significance.

    • The maximum number of authors is 6.

    • Do not enter names of authors or affiliations in the abstract template, as your abstract needs to remain unidentifiable to the reviewers. As you will need to enter this information elsewhere on line, the system will make the correct link between your name and abstract.

    • The first author of each abstract will be considered the presenting and corresponding author. The presenting author is requested to provide her/his full address (including e-mail address).

    • Each author is allowed to be the first author in maximum two abstracts. There is no limit to be co-authors in other abstracts.

    • Posters will be displayed as e-posters on screens.

    • Preference will be given to submissions which have not been previously presented or published.

    • Authors whose abstracts are accepted for presentation must register for the conference and pay the registration fee. Presenting authors of accepted abstracts (1 author per abstract) will be eligible for Early Bird registration fee. 

    Accepted abstracts

    • All accepted abstracts will be ranked according to scoring.

    • Principle authors of the highest scored 5 abstracts will be invited for oral presentation in a plenary session (Session 2 - Friday 16th June 2023, 10.00 h.) by the scientific committee. Authors will be notified in advance.

    • Presenting author of the abstract with the highest scoring will be honoured with the PCDE Best Conference Abstract Award of 1.000 Euro* during the closing ceremony by the chair of the PCDE. The author will be notified in advance.

    • Authors of the highest ranking first 20 posters will be invited to present their work in guided poster walk sessions organized during the coffee breaks. All presenting authors are requested to be in front of their poster during the poster walk sessions in order to discuss their work with the chair and participants of the poster walk. Authors will be notified in advance.

    • The rest of accepted abstracts will be displayed as e-posters rotating on digital screens. Authors will no longer be required to display printed posters.

    • All accepted posters will be displayed on an e-poster gallery on the official conference website (after the conference).

    • Selected abstract may be solicited for publication in Primary Care Diabetes, the indexed, peer reviewed journal of PCDE, by members of its Editorial Board.

    (*subject to local taxation)

    BEST CONFERENCE ABSTRACT AWARD

    Presenting author of the abstract with the highest scoring will be honoured with the PCDE Best Conference Abstract Award of 1.000 Euro* during the closing ceremony by the chair of the PCDE. The author will be notified in advance.
    (*subject to local taxation)

    How to submit an abstract?

    1. Register as a new author on this website (click on "New authors").

    2. You must define your "Username" and "Password".

    3. Click on "Submit abstract" and enter the username and password given.

    4. Enter your abstract following the instructions.

    5. Abstracts can be modified after being submitted (but only until January 31st, 2023).

    6. You will need this username and password to check the status of the abstracts submitted.

    7. Please remember ABSTRACT submission deadlines:
      • FAST TRACK REVIEW* deadline:     JANUARY 31st, 2023    
      • REGULAR deadline:                          Extended until APRIL 13th, 2023   (Abstract submission system will be automatically closed after this date)

    Submit your abstract

    Evaluation procedure and criteria

    Abstracts will be peer reviewed by at least two independent blinded reviewers, with the following assessment criteria:

    • The abstract is relevant to Diabetes Care in General Practice, in accordance with the core competencies featured in the definition of General Practice/Family Medicine (WONCA 2005)?
      • If no please justify your rejection:
    • The aim or research question is clear? (1 to 4)
         (1: insufficient or limited             2: fair              3: good                4: excellent)
    • The study design is appropriate to answer the research question? (1 to 4)
    • The results could be implemented into primary care practice? (1 to 4)
    • The conclusions are based on the results and consistent with the aim? (1 to 4)
    • The work is innovative (concerning research question, topic or methods? (1 to 4)

    From all abstracts a top 5 selection will be suggested by the Scientific Committee. These 5 abstracts will be presented orally during a plenary session of the conference (Session 2 - Friday 16th June 2023, 10.00 - 10.40h.). Authors will be informed in advance.

    Presenting author of the abstract with the highest scoring will be honoured with the PCDE Best Conference Abstract Award of 1.000 Euro* during the closing ceremony by the chair of the PCDE. The author will be notified in advance.

    Authors of the highest ranking first 30 posters will be invited to present their work in guided poster walk sessions organized during the coffee breaks. All presenting authors are requested to be in front of their poster during the poster walk sessions in order to discuss their work with the chair and participants of the poster walk. Authors will be notified in advance.

    Notification of ACCEPTANCE

    • Fast Track submission: abstracts submitted before January 31st, 2023 will be eligible to fast track review and authors will receive notification of acceptance within 2 weeks after submission (February 15th, 2023).

    • Regular submission: confirmation of acceptance or rejection by the scientific committee will be published on the conference website on MAY 8th, 2023.

    • The Jury will decide on the 5 best abstracts which will be shared in an oral presentation during in Session 2 of the conference, and detailed practical information regarding the presentation (oral or poster) will be published on the conference website on MAY 8th, 2023.

    Assistance

    Should you need to contact the Conference Technical Secretariat: congresos@semfyc.es